Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
63.6M
-
Number of holders
-
226
-
Total 13F shares, excl. options
-
64.6M
-
Shares change
-
-341K
-
Total reported value, excl. options
-
$3.42B
-
Value change
-
-$18.8M
-
Put/Call ratio
-
0.16
-
Number of buys
-
126
-
Number of sells
-
-88
-
Price
-
$52.97
Significant Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q1 2025
259 filings reported holding RYTM - RHYTHM PHARMACEUTICALS, INC. - COM as of Q1 2025.
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) has 226 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.6M shares
.
Largest 10 shareholders include BlackRock, Inc. (6.85M shares), RA CAPITAL MANAGEMENT, L.P. (6.08M shares), PRIMECAP MANAGEMENT CO/CA/ (5.79M shares), BAKER BROS. ADVISORS LP (5.6M shares), VANGUARD GROUP INC (3.44M shares), NEA Management Company, LLC (2.91M shares), PERCEPTIVE ADVISORS LLC (2.55M shares), STATE STREET CORP (1.97M shares), FMR LLC (1.69M shares), and JANUS HENDERSON GROUP PLC (1.66M shares).
This table shows the top 226 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.